218 related articles for article (PubMed ID: 15159360)
1. Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.
Cheung AM; Feig DS; Kapral M; Diaz-Granados N; Dodin S;
CMAJ; 2004 May; 170(11):1665-7. PubMed ID: 15159360
[No Abstract] [Full Text] [Related]
2. Evaluation and treatment of postmenopausal osteoporosis.
Wang CY; Bruder JM; Rubin CD
Am J Manag Care; 2001 Sep; 7 Spec No():SP5-16. PubMed ID: 11599675
[TBL] [Abstract][Full Text] [Related]
3. Maintaining skeletal health among postmenopausal women.
Ettinger B
Am J Manag Care; 1998 Mar; 4(3):387-96. PubMed ID: 20919444
[TBL] [Abstract][Full Text] [Related]
4. Treatment considerations in the management of age-related osteoporosis.
Rubin CD
Am J Med Sci; 1999 Sep; 318(3):158-70. PubMed ID: 10487406
[No Abstract] [Full Text] [Related]
5. Raloxifene: a new choice for treating and preventing osteoporosis.
Licata AA; Ciaccia AV; Wong M; Draper MW
Cleve Clin J Med; 2000 Apr; 67(4):273-80. PubMed ID: 10780099
[TBL] [Abstract][Full Text] [Related]
6. ERT, HRT, raloxifine, calcitonin, or bisphosphonates for osteoporosis.
Curtiss FR
J Manag Care Pharm; 2003; 9(2):178-81. PubMed ID: 14613350
[No Abstract] [Full Text] [Related]
7. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.
Martens MG
J Reprod Med; 2003 Jun; 48(6):425-34. PubMed ID: 12856513
[TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
Pfeilschifter J
Orthopade; 2001 Jul; 30(7):462-72. PubMed ID: 11515185
[TBL] [Abstract][Full Text] [Related]
9. The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis.
Lufkin EG; Wong M; Deal C
Rheum Dis Clin North Am; 2001 Feb; 27(1):163-85, vii. PubMed ID: 11285993
[TBL] [Abstract][Full Text] [Related]
10. Prevention of corticosteroid-induced osteoporosis and fractures.
O'Mahony D
J Clin Pharm Ther; 1999 Apr; 24(2):83-5. PubMed ID: 10380059
[No Abstract] [Full Text] [Related]
11. Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.
Reginster JY; Felsenberg D; Pavo I; Stepan J; Payer J; Resch H; Glüer CC; Mühlenbacher D; Quail D; Schmitt H; Nickelsen T
Osteoporos Int; 2003 Sep; 14(9):741-9. PubMed ID: 12827224
[TBL] [Abstract][Full Text] [Related]
12. Fracture prevention in postmenopausal osteoporosis: a review of treatment options.
McCarus DC
Obstet Gynecol Surv; 2006 Jan; 61(1):39-50. PubMed ID: 16359568
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of postmenopausal osteoporosis with raloxifene].
Fedelesova V; Chylova K; Dzurik
Bratisl Lek Listy; 2000; 101(9):527-8. PubMed ID: 11187059
[TBL] [Abstract][Full Text] [Related]
14. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.
Cauley JA; Norton L; Lippman ME; Eckert S; Krueger KA; Purdie DW; Farrerons J; Karasik A; Mellstrom D; Ng KW; Stepan JJ; Powles TJ; Morrow M; Costa A; Silfen SL; Walls EL; Schmitt H; Muchmore DB; Jordan VC; Ste-Marie LG
Breast Cancer Res Treat; 2001 Jan; 65(2):125-34. PubMed ID: 11261828
[TBL] [Abstract][Full Text] [Related]
15. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
[TBL] [Abstract][Full Text] [Related]
16. [Osteoporosis: diagnosis, prevention and treatment].
Baranauskaite A; Savickiene A
Medicina (Kaunas); 2002; 38(2):234-9; quiz 240. PubMed ID: 12474746
[TBL] [Abstract][Full Text] [Related]
17. [Osteoporosis priority: Reduce the number of fractures].
Roux C
Presse Med; 2006 Oct; 35(10 Pt 2):1527-8. PubMed ID: 17028516
[No Abstract] [Full Text] [Related]
18. Diagnosing and managing post menopausal osteoporosis: opportunities for fracture prevention.
McGarry KA; Tammaro D; Cyr MG
Compr Ther; 2003; 29(2-3):115-23. PubMed ID: 14606341
[TBL] [Abstract][Full Text] [Related]
19. Proportion and Characteristics of Patients in Sweden Remaining at High Risk of Fracture Despite Prior Treatment.
Mellström D; Yang X; Li Z; Fan CP; Waern E; Modi A; Sajjan S; Salomonsson S
Clin Ther; 2016 Jul; 38(7):1686-1695.e3. PubMed ID: 27288211
[TBL] [Abstract][Full Text] [Related]
20. Selective estrogen receptor modulators and postmenopausal women's health.
Hol T; Cox MB; Bryant HU; Draper MW
J Womens Health; 1997 Oct; 6(5):523-31. PubMed ID: 9356975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
